Cancer Genetics Inc. (Nasdaq: CGIX) is buying BioServe India for $1.9 million.
The acquisition is meant to help the Rutherford, N.J.-based buyer capitalize on the growing clinical diagnostics market in the India and Asian markets.
Complete access to real-time information and analysis of news and trends in the industry.
14-Day Free Trial
No credit card required. Complete access to articles, breaking news and industry data.
Have an account? Sign In